Emerging themes around the T-cell response & COVID-19

Can adjuvants & immune profiling improve our immune response to current COVID vaccines?

Our panel discussion with Sharon Benzeno, Chief Business Development Officer, Adaptive Biotechnologies.

Presented by:

Sharon Benzeno, Chief Business Development Officer, Adaptive Biotechnologies
Ofer Levy, Director, Precision Vaccines Program, Boston Children’s Hospital, Harvard Medical School
Tyler Martin, Chairman, President & CEO, Adjuvance Technologies
Alessandro Sette, Center Head, Division Head, & Professor, La Jolla Institute For Allergy & Immunology
Wolfgang Leitner, Chief Innate Immunity Section National Institute of Health-NIAID

T-cell immune response: Exploring emerging themes in vaccine development & COVID-19 variants

Explore the cellular mechanisms underlying the response to SARS-CoV-2 with Dr. Harlan Robins, who discussed our data around COVID-19 and our work in the vaccine space. Watch on-demand now to find out more about how the immunoSEQ® Technology is driving discovery and insights in the field.

Presented by: Harlan Robins, PhD, CSO & Co-founder, Adaptive Biotechnologies

Register for SEQdiscovery

To access these videos and all SEQdiscovery content.
If you have previously registered and opted to have an account please log in above.